Adverum Biotechnologies (ADVM) Insider Trading & Ownership → READ THIS – If You Missed Out On The AI Boom (From Banyan Hill Publishing) (Ad) Free ADVM Stock Alerts $9.77 +0.24 (+2.52%) (As of 03:45 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Adverum Biotechnologies (NASDAQ:ADVM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage5.30%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$135,000.00Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$9,424.00 Get ADVM Insider Trade Alerts Want to know when executives and insiders are buying or selling Adverum Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ADVM Insider Buying and Selling by Quarter Ad Porter & CompanyTruth about Trump you’ve never heardEverything about Donald Trump is public. Every part of his life has been dragged out in the media. But there’s one story I bet you’ve never heard about Trump. For the full story, click here. Adverum Biotechnologies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/7/2024James Paul ScopaDirectorBuy10,000$13.50$135,000.00 9/15/2023Setareh SeyedkazemiInsiderSell620$15.20$9,424.00 (Data available from 1/1/2013 forward) ADVM Insider Trading Activity - Frequently Asked Questions Who is on Adverum Biotechnologies's Insider Roster? The list of insiders at Adverum Biotechnologies includes Brigit Riley, Dawn Svoronos, James Paul Scopa, Julie Clark, Laurent Fischer, Peter Soparkar, Richard Beckman, Rupert D'souza, and Setareh Seyedkazemi. Learn more on insiders at ADVM. What percentage of Adverum Biotechnologies stock is owned by insiders? 5.30% of Adverum Biotechnologies stock is owned by insiders. Learn more on ADVM's insider holdings. Which Adverum Biotechnologies insiders have been buying company stock? The following insiders have purchased ADVM shares in the last 24 months: Dawn Svoronos ($25,500.00), James Paul Scopa ($135,000.00), Rupert D'souza ($16,900.00), and Setareh Seyedkazemi ($16,800.00). How much insider buying is happening at Adverum Biotechnologies? Insiders have purchased a total of 17,000 ADVM shares in the last 24 months for a total of $194,200.00 bought. Which Adverum Biotechnologies insiders have been selling company stock? The following insiders have sold ADVM shares in the last 24 months: Brigit Riley ($5,686.20), Laurent Fischer ($76,115.00), Peter Soparkar ($10,420.80), Richard Beckman ($4,568.90), and Setareh Seyedkazemi ($9,424.00). How much insider selling is happening at Adverum Biotechnologies? Insiders have sold a total of 11,343 Adverum Biotechnologies shares in the last 24 months for a total of $106,214.90 sold. More Insider Trading Tools from MarketBeat Related Companies: STRO Insider Trades ELEV Insider Trades CMPX Insider Trades CHRS Insider Trades PSTX Insider Trades XFOR Insider Trades FENC Insider Trades IPSC Insider Trades BDTX Insider Trades MGX Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: The 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1 This page (NASDAQ:ADVM) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarProtect Your Bank Account Before It’s Too LateWeiss RatingsHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportTruth about Trump you’ve never heardPorter & CompanyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adverum Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.